Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$97.47 USD
-0.68 (-0.69%)
Updated Sep 25, 2023 04:03 PM ET
2-Buy of 5 2
C Value F Growth D Momentum F VGM
Detailed Estimates
Estimates
Exp Earnings Date | 10/18/23 |
---|---|
Current Quarter | 1.10 |
EPS Last Quarter | 1.08 |
Last EPS Surprise | 3.85% |
ABR | 1.56 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.40 |
Next Year | 4.60 |
EPS (TTM) | 4.29 |
P/E (F1) | 22.16 |
Sales Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.78B | 10.27B | 39.77B | 41.70B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 9.88B | 10.41B | 39.95B | 42.04B |
Low Estimate | 9.69B | 10.20B | 39.64B | 41.27B |
Year ago Sales | 10.41B | 10.09B | 43.65B | 39.77B |
Year over Year Growth Est. | -6.09% | 1.80% | -8.89% | 4.86% |
Earnings Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.10 | 1.19 | 4.40 | 4.60 |
# of Estimates | 9 | 7 | 10 | 10 |
Most Recent Consensus | 1.10 | 1.17 | 4.38 | 4.58 |
High Estimate | 1.10 | 1.21 | 4.41 | 4.75 |
Low Estimate | 1.10 | 1.17 | 4.38 | 4.53 |
Year ago EPS | 1.15 | 1.03 | 5.34 | 4.40 |
Year over Year Growth Est. | -4.35% | 15.53% | -17.60% | 4.59% |
Agreement - Estimate Revisions
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | 1.10 | 1.19 | 4.40 | 4.60 |
7 Days Ago | 1.10 | 1.19 | 4.40 | 4.60 |
30 Days Ago | 1.10 | 1.19 | 4.40 | 4.60 |
60 Days Ago | 1.10 | 1.19 | 4.40 | 4.60 |
90 Days Ago | 1.10 | 1.20 | 4.39 | 4.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.10 | 1.19 | 4.40 | 4.60 |
Zacks Consensus Estimate | 1.10 | 1.19 | 4.40 | 4.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Quarter Ending (9/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.08 | 1.03 | 1.03 | 1.15 | NA |
Estimate | 1.04 | 0.98 | 0.90 | 0.91 | NA |
Difference | 0.04 | 0.05 | 0.13 | 0.24 | 0.12 |
Surprise | 3.85% | 5.10% | 14.44% | 26.37% | 12.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more